Bloomage BioTechnology Corporation Limited (SHA:688363)
China
· Delayed Price · Currency is CNY 45.24
+0.47 (1.05%)
Mar 10, 2026, 2:14 PM CST
SHA:688363 Revenue
In the year 2025, Bloomage BioTechnology Corporation had annual revenue of 4.22B CNY, down -21.49%. Bloomage BioTechnology Corporation had revenue of 1.05B in the quarter ending December 31, 2025, a decrease of -29.58%.
Revenue
4.22B
Revenue Growth
-21.49%
P/S Ratio
5.08
Revenue / Employee
948.88K
Employees
3,860
Market Cap
21.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.22B | -1.15B | -21.49% |
| Dec 31, 2024 | 5.37B | -705.15M | -11.61% |
| Dec 31, 2023 | 6.08B | -283.27M | -4.45% |
| Dec 31, 2022 | 6.36B | 1.41B | 28.53% |
| Dec 31, 2021 | 4.95B | 2.32B | 87.93% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanxiang Advanced Materials | 1.06B |
| Guangdong Dowstone Technology | 7.64B |
| Novoray | 1.12B |
| Peric Special Gases | 2.14B |
| Jiangsu Sidike New Materials Science & Technology | 2.92B |
| Aerospace Intelligent Manufacturing Technology | 9.00B |
| Dalian BIO-CHEM Company | 1.47B |
| Zhejiang Jiemei Electronic And Technology | 2.00B |